Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas.

Clear-cut inherited Mendelian traits, such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer, account for <4% of colorectal cancers. Another 20% of all colorectal cancers are thought to occur in individuals with a significant inherited multifactorial susceptibility to colorectal cancer that is not obviously familial. Incompletely penetrant, comparatively rare missense variants in the adenomatous polyposis coli gene, which is responsible for familial adenomatous polyposis, have been described in patients with multiple colorectal adenomas. These variants represent a category of variation that has been suggested, quite generally, to account for a substantial fraction of such multifactorial inherited susceptibility. The aim of this study was to explore this rare variant hypothesis for multifactorial inheritance by using multiple colorectal adenomas as the model. Patients with multiple adenomas were screened for germ-line variants in a panel of candidate genes. Germ-line DNA was obtained from 124 patients with between 3 and 100 histologically proven synchronous or metachronous adenomatous polyps. All patients were tested for the adenomatous polyposis coli variants I1307K and E1317Q, and variants were also sought in AXIN1 (axin), CTNNB1 (beta-catenin), and the mismatch repair genes hMLH1 and hMSH2. The control group consisted of 483 random controls. Thirty of 124 (24.9%) patients carried potentially pathogenic germ-line variants as compared with 55 ( approximately 12%) of the controls. This overall difference is highly significant, suggesting that many rare variants collectively contribute to the inherited susceptibility to colorectal adenomas.

[1]  F. Collins,et al.  The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer , 2004, Nature Genetics.

[2]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[3]  T. Postelnicu,et al.  Sokal, R. R., and I. J. Rohlf: Biometry. W. H. Freeman and Company, San Francisco 1969, XXI + 776 S., 89 Abb., 56 Tab., Preis 126/— , 1970 .

[4]  W F Bodmer,et al.  The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea , 2000, Gut.

[5]  W. Foulkes,et al.  A636P is associated with early-onset colon cancer in Ashkenazi Jews. , 2003, Journal of the American College of Surgeons.

[6]  T. Dale,et al.  Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding , 2000, Genes, chromosomes & cancer.

[7]  D. Ransohoff,et al.  Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. , 2000, The New England journal of medicine.

[8]  F. Costantini,et al.  Identification of a Domain of Axin That Binds to the Serine/Threonine Protein Phosphatase 2A and a Self-binding Domain* , 1999, The Journal of Biological Chemistry.

[9]  H. Müller,et al.  Germline mutations in the β-catenin gene are not associated with the FAP phenotype without an APC mutation , 1999, Journal of medical genetics.

[10]  R. Fishel,et al.  Interactions of Human hMSH2 with hMSH3 and hMSH2 with hMSH6: Examination of Mutations Found in Hereditary Nonpolyposis Colorectal Cancer , 1998, Molecular and Cellular Biology.

[11]  Akira Kikuchi,et al.  DIX Domains of Dvl and Axin Are Necessary for Protein Interactions and Their Ability To Regulate β-Catenin Stability , 1999, Molecular and Cellular Biology.

[12]  D. Lieberman,et al.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. , 2000, The New England journal of medicine.

[13]  N. Raab-Traub,et al.  I-mfa Domain Proteins Interact with Axin and Affect Its Regulation of the Wnt and c-Jun N-Terminal Kinase Signaling Pathways , 2002, Molecular and Cellular Biology.

[14]  W. Bodmer,et al.  Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Luigi Luca Cavalli-Sforza,et al.  The genetics of human populations. , 1972, Scientific American.

[16]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[17]  R. Houlston,et al.  Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. , 1990, BMJ.

[18]  J. Pritchard.  Are rare variants responsible for susceptibility to complex diseases? , 2001, American journal of human genetics.

[19]  A. Cats,et al.  Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. , 1996, American journal of human genetics.

[20]  R. Houlston,et al.  Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer , 2002, Oncogene.

[21]  W F Bodmer,et al.  Beta-catenin mutations in cell lines established from human colorectal cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Fishel,et al.  The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer* , 1999, The Journal of Biological Chemistry.

[23]  M. D'urso,et al.  Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer , 2002, Genes, chromosomes & cancer.

[24]  P. Hartge,et al.  The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews , 1998, Nature Genetics.

[25]  A. Lindblom,et al.  Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. , 1995, Cancer research.

[26]  P Rozen,et al.  Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. , 1999, Gastroenterology.

[27]  F. Berthold,et al.  Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. , 2001, Cancer research.

[28]  H. Campbell,et al.  Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. , 2002, American journal of epidemiology.

[29]  S. Gallinger,et al.  Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. , 1999, American journal of human genetics.

[30]  Yusuke Nakamura,et al.  Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney , 2001, Oncogene.

[31]  W F Bodmer,et al.  The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Prolla,et al.  Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to human hereditary nonpolyposis colorectal cancer-associated mutations , 1997, Molecular and cellular biology.

[33]  I Tomlinson,et al.  Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. , 2000, Human molecular genetics.

[34]  H. Ostrer,et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.

[35]  Yusuke Nakamura,et al.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.

[36]  W F Bodmer,et al.  The ABC of APC. , 2001, Human molecular genetics.

[37]  L. Aaltonen,et al.  The I1307K polymorphism of the APC gene in colorectal cancer. , 1999, Gastroenterology.

[38]  P. Tran,et al.  Functional Studies on the Candidate ATPase Domains of Saccharomyces cerevisiae MutLα , 2000, Molecular and Cellular Biology.

[39]  W. Bodmer.  Familial adenomatous polyposis (FAP) and its gene, APC , 1999, Cytogenetic and Genome Research.

[40]  T. Meitinger,et al.  DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. , 2001, Journal of biochemical and biophysical methods.

[41]  Hideki Yamamoto,et al.  Axin, a Negative Regulator of the Wnt Signaling Pathway, Directly Interacts with Adenomatous Polyposis Coli and Regulates the Stabilization of β-Catenin* , 1998, The Journal of Biological Chemistry.

[42]  C. Ban,et al.  Transformation of MutL by ATP Binding and Hydrolysis A Switch in DNA Mismatch Repair , 1999, Cell.

[43]  J. Wardle,et al.  Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening , 2001, Journal of medical screening.

[44]  M. Vatn,et al.  Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. , 1999, Scandinavian journal of gastroenterology.

[45]  T. Akiyama,et al.  Axin, an inhibitor of the Wnt signalling pathway, interacts with β‐catenin, GSK‐3β and APC and reduces the β‐catenin level , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[46]  Paul Polakis,et al.  Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β , 1998, Current Biology.

[47]  J Straub,et al.  APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  W. Bodmer,et al.  Alkaline-mediated differential interaction (AMDI): A simple automatable single-nucleotide polymorphism assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Dale,et al.  Interaction of Axin and Dvl‐2 proteins regulates Dvl‐2‐stimulated TCF‐dependent transcription , 1999, The EMBO journal.

[50]  Morson Bc,et al.  The Polyp-cancer Sequence in the Large Bowel , 1974 .

[51]  David I. Smith,et al.  Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas , 2002, Oncogene.

[52]  P. Peltomäki,et al.  Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. , 1997, Gastroenterology.

[53]  S. Friend,et al.  Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae , 1998, Nature Genetics.

[54]  F. Molemans,et al.  Genomic organization of the human beta-catenin gene (CTNNB1). , 1996, Genomics.

[55]  L. Lipton,et al.  Germline mutations in the TGF-β and Wnt signalling pathways are a rare cause of the “multiple” adenoma phenotype , 2003, Journal of medical genetics.